A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18–49 years of age

Published:2012-04 Issue:20 Volume:30 Page:3053-3060
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Baxter Roger,Toback Seth L.,Sifakis Frangiscos,Hansen John,Bartlett Joan,Aukes Laurie,Lewis Ned,Wu Xionghua,Ambrose Christopher S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference24 articles.

1. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP);Fiore;MMWR Recomm Rep,2010

2. The impact of influenza on working days lost: a review of the literature;Keech;Pharmacoeconomics,2008

3. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents;Bergen;Pediatr Infect Dis J,2004

4. Serum antibody responses after intradermal vaccination against influenza;Belshe;N Engl J Med,2004

5. Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age;Belshe;Vaccine,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facial paralysis and vaccinations: a vaccine adverse event reporting system review;Family Practice;2021-06-29

2. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis;Vaccine;2021-06

3. Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review;BMJ Global Health;2019-07

4. Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma;Vaccine;2019-07

5. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children;Vaccine;2018-04